ISPNOInternational Symposium on Pediatric Neuro-Oncology
References in periodicals archive ?
NewLink Genetics reported that updated Phase 1 data evaluating indoximod plus front-line radiation and maintenance chemotherapy for the treatment of pediatric patients with newly diagnosed diffuse intrinsic pontine glioma, or DIPG, were presented at the International Symposium of Pediatric Neuro-Oncology, or ISPNO. Data were presented on ten newly diagnosed DIPG patients, all of whom had initiated therapy at the time of this assessment.